Birmingham, ALNCT07204340Now EnrollingIRB Ready

KRAS Mutant Solid Tumors Clinical Trial in Birmingham, AL

Access cutting-edge kras mutant solid tumors treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.

Sponsored by Treeline Biosciences, Inc.

Quick Self-Assessment

See if you qualify for this Birmingham location

Preparing your pre-screening questions…

Expert Care in Birmingham

Access kras mutant solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related kras mutant solid tumors treatment provided free

Apply for This Birmingham Location

Check if you qualify for this kras mutant solid tumors clinical trial in Birmingham, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Birmingham

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Birmingham site if eligible
  4. 4Begin participation

About This KRAS Mutant Solid Tumors Study in Birmingham

The primary purpose of this study is to evaluate the safety, pharmacokinetics, and anti-tumor activity of TLN-372 as a single agent and in combination with other anti-tumor agents, in patients with advanced KRAS mutant solid tumors

Sponsor: Treeline Biosciences, Inc.

Who Can Participate

Inclusion Criteria

Patients must have measurable disease at study entry.
Patients must have locally advanced or metastatic KRAS mutant solid tumors.
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
Adequate organ function.

Exclusion Criteria

Patients must not have active brain metastases.
Patients must not have current or past history of central nervous system (CNS) involvement.
Patients must not have major surgery or severe trauma within 4 weeks prior to the start of the study.
Patients must not have any condition, including significant acute or chronic medical illness, active or uncontrolled infection, or the presence of laboratory abnormalities, that places patients at unacceptable risk of participating in this study.
Patients must not have clinically significant cardiovascular disease.
Pregnant or lactating.
Conditions that could affect drug absorption.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Birmingham?

Yes, this clinical trial (NCT07204340) has an active research site in Birmingham, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

KRAS Mutant Solid Tumors Treatment Options in Birmingham, AL

If you're searching for kras mutant solid tumors treatment options in Birmingham, AL, this clinical trial (NCT07204340) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kras mutant solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all kras mutant solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Birmingham, AL

See all advanced solid tumors clinical trials recruiting in Birmingham — not just this study.

Browse Advanced Solid Tumors Trials in Birmingham →

Browse More Trials by Condition

Advanced Solid Tumors TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Birmingham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Birmingham, AL